Subgroups of Sjögren syndrome patients according to serological profiles
VK Bournia, PG Vlachoyiannopoulos - Journal of autoimmunity, 2012 - Elsevier
Sjögren Syndrome (SS) is a systemic, autoimmune disorder characterized by lymphocytic
infiltration of the exocrine glands. Different clinical associations have been described for each …
infiltration of the exocrine glands. Different clinical associations have been described for each …
Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort
S Panopoulos, VK Bournia, G Konstantonis… - Autoimmunity …, 2018 - Elsevier
Objectives To determine predictors of morbidity and mortality in systemic sclerosis (SSc) in
a long-term follow-up of an inception cohort of early SSc patients. Methods We evaluated …
a long-term follow-up of an inception cohort of early SSc patients. Methods We evaluated …
Therapeutic inhibition of tyrosine kinases in systemic sclerosis: a review of published experience on the first 108 patients treated with imatinib
VK Bournia, K Evangelou, PP Sfikakis - Seminars in arthritis and …, 2013 - Elsevier
OBJECTIVE: Experimental and clinical evidence suggest a therapeutic role for the tyrosine
kinase inhibitor imatinib in fibrosing conditions. We evaluated published data on the safety …
kinase inhibitor imatinib in fibrosing conditions. We evaluated published data on the safety …
[HTML][HTML] Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis
VKK Bournia, KD Diamanti… - Arthritis research & …, 2010 - Springer
Introduction A subgroup of patients with primary Sjögren's Syndrome (SS) and positive
anticentromere antibodies (ACA) were recognized as having features intermediate between SS …
anticentromere antibodies (ACA) were recognized as having features intermediate between SS …
Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides
…, M Douskou, D Panagiotakos, V Bournia… - Arthritis Care & …, 2009 - Wiley Online Library
Objective Myocardium and coronary arteries can occasionally be affected in patients with
systemic necrotizing vasculitides; however, such involvement has not been systematically …
systemic necrotizing vasculitides; however, such involvement has not been systematically …
Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases
…, K Fragiadaki, G Evangelatos, VK Bournia… - Annals of the …, 2022 - ard.bmj.com
Objective Τo report outcomes of breakthrough COVID-19 in comparison with COVID-19 in
unvaccinated patients with systemic rheumatic diseases (SRDs). Methods Patients with SRD …
unvaccinated patients with systemic rheumatic diseases (SRDs). Methods Patients with SRD …
All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019
VK Bournia, GE Fragoulis, P Mitrou, K Mathioudakis… - RMD open, 2021 - rmdopen.bmj.com
Objectives To compare current all-cause mortality rates in rheumatoid arthritis (RA),
ankylosing spondylitis (AS), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE) and …
ankylosing spondylitis (AS), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE) and …
Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic
…, G Evangelatos, A Arida, VK Bournia… - Annals of the …, 2021 - ard.bmj.com
We read with great interest the preliminary German Society of Rheumatology recommendations
for the management of patients with autoimmune inflammatory rheumatic diseases (…
for the management of patients with autoimmune inflammatory rheumatic diseases (…
[HTML][HTML] COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
GE Fragoulis, VK Bournia, E Mavrea… - Rheumatology …, 2022 - Springer
Objective To describe the rate and type of adverse effects (AEs) and the frequency of disease
flares after COVID-19 vaccination and to assess the reasons for vaccination hesitancy (non…
flares after COVID-19 vaccination and to assess the reasons for vaccination hesitancy (non…
Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases
…, E Sfendouraki, S Panopoulos, V Bournia… - Arthritis Care & …, 2014 - Wiley Online Library
Objective Accurate diagnosis of cardiovascular involvement in connective tissue diseases (CTDs)
remains challenging. We hypothesized that cardiovascular magnetic resonance (CMR…
remains challenging. We hypothesized that cardiovascular magnetic resonance (CMR…